Search filters

A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND).

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article
Author/s

author: José Cunha-Vaz  Dalila Alves 

Publication date February 9, 2017
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item